rintatolimod
Commercial- Indications
- Chronic Fatigue Syndrome, Pancreatic cancer
Company intelligence / Profile preview
BioPro
Kiev/Kyiv, Ukraineannualreports.com ↗
- Ownership
- Public · AIM
- Development stage
- Commercial
01
Overview
Biopro Stem Technology operates a modern biotechnological center focused on regenerative medicine using autologous mesenchymal stem cell therapies. The company has demonstrated safety and efficacy in pilot clinical trials for vascular, metabolic, hepatic, and autoimmune diseases. It collaborates with leading Ukrainian medical institutions and was recognized with an international quality award in 2015.
- Therapeutic areas
- GastroenterologyEndocrinologyCardiovascularImmunology
- Modalities
- Autologous stem cells (mesenchymal stem cells)Regenerative medicine technologies
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
National Academy of Medical Sciences of UkraineState Institute of Genetic and Regenerative MedicineMinistry of Defence Ukraine.
04
Financials
- Market cap
- $781.8K
- Total revenue
- $26K
- Enterprise value
- $-5.3M
Beyond the preview
Go deeper on BioPro.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioPro.